HCPCS code J0666 — Inj, bupivacaine liposome.
Status: Active.
Effective Jan 1, 2025.
Source: CMS HCPCS Level II.
J0666
ActiveInj, bupivacaine liposome
Injection, bupivacaine liposome, 1 mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jan 1, 2025
Code type:
alphanumeric
OPPS Status:
K1
OPPS APC:
0763
MUE — Medically Unlikely Edits
Maximum units of J0666 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| DME Supplier | 266 |
| Outpatient Hospital | 266 |
| Practitioner Services | 266 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 65250-0133-04 | Exparel |
| 65250-0133-09 | Exparel |
| 65250-0266-04 | Exparel |
| 65250-0266-09 | Exparel |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2025-Q1Inj, bupivacaine liposome